RSV infection with inflammatory bowel disease ups risk for hospitalization
By
Haymarket Media
Aug 28, 2024
“Adult patients with IBD and RSV infection … may benefit from the new RSV vaccine recommended for adults aged 60 years and older,” the authors write.
FDA approves updated COVID shots for fall
Aug 22, 2024
Updated shots to shield against COVID-19 infection were approved by the US Food and Drug Administration on Thursday.
How will new federal legislation cut drug costs?
Aug 12, 2022
Under the law, Medicare will now be allowed to negotiate the cost of some drugs, and vaccines will be free for Part D recipients.
New U.S. COVID-19 vaccinations climb for the longest stretch in months
Nov 05, 2021
At least some of the recent surge in first doses also could be from incorrectly reported booster shots, however.
Prior SARS-CoV-2 infection ups protection for vaccinated
Nov 15, 2021
Prior infection was linked to a lower risk for breakthrough infection among individuals vaccinated with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna).
Protection against omicron strongest with hybrid immunity
Jun 17, 2022
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers the strongest protection against the omicron infection.
CDC advises updated COVID vaccine for everyone over 6 months of age
Jun 28, 2024
Americans 65 and older account for two-thirds of COVID hospitalizations and 82% of in-hospital deaths, yet only about 40% of Americans in that age group were immunized with the COVID vaccines that were...
Breakthrough SARS-CoV-2 infections ID’d in fully vaccinated
Aug 02, 2021
39 infections documented in 1,497 health care workers; 19 percent had persistent symptoms despite most cases being mild, asymptomatic
COVID-19 vaccination bests natural immunity for cutting death, hospitalizations
Dec 28, 2022
Natural immunity, however, was tied to a lower incidence of new infection.
Risk for breakthrough SARS-CoV-2 infection lower with mRNA-1273
Feb 02, 2022
The risk for breakthrough infection and of 60-day hospitalization was significantly lower for mRNA-1273 (Moderna) versus BNT162b2 (Pfizer-BioNTech) vaccination.